Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
McBennett, K.
16  Ergebnisse:
Personensuche X
?
1

WS05.06 Phase 1/2a randomized, double-blind, placebo-contro..:

Cohen, A. ; Lechtzin, N. ; Boas, S....
Journal of Cystic Fibrosis.  22 (2023)  - p. S11 , 2023
Link: https://doi.org/10.1016/..
 
?
2

723 Nocturnal pulse oximetry studies before and after initi..:

Heritage, R. ; Allerton, P. ; McBennett, K.
Journal of Cystic Fibrosis.  22 (2023)  - p. S400 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Inhaled mRNA therapy for treatment of cystic fibrosis: Inte..:

Rowe, S.M. ; Zuckerman, J.B. ; Dorgan, D....
Journal of Cystic Fibrosis.  22 (2023)  4 - p. 656-664 , 2023
Link: https://doi.org/10.1016/..
 
?
4

439 Neurologic and mental health adverse events with CFTR m..:

Jeghers, M. ; McBennett, K. ; Roesch, E..
Journal of Cystic Fibrosis.  22 (2023)  - p. S230-S231 , 2023
Link: https://doi.org/10.1016/..
 
?
5

114 Lung T1-MRI and multiple breath washout detect longitud..:

Nasr, S. ; MacAskill, C. ; Kretzler, M....
Journal of Cystic Fibrosis.  22 (2023)  - p. S60-S61 , 2023
Link: https://doi.org/10.1016/..
 
?
6

248 Self-reported adherence to concomitant medications by a..:

Kenney, L. ; Roesch, E. ; McBennett, K....
Journal of Cystic Fibrosis.  21 (2022)  - p. S148 , 2022
Link: https://doi.org/10.1016/..
 
?
7

116 Associations between lung T1 magnetic resonance imaging..:

Ren, C. ; Slaven, J. ; Nasr, S...
Journal of Cystic Fibrosis.  21 (2022)  - p. S68-S69 , 2022
Link: https://doi.org/10.1016/..
 
?
8

185 Long-term safety and efficacy of elexacaftor/tezacaftor..:

Chmiel, J. ; Barry, P.J. ; Colombo, C....
Journal of Cystic Fibrosis.  21 (2022)  - p. S108-S109 , 2022
Link: https://doi.org/10.1016/..
 
?
9

229 Impact of cystic fibrosis transmembrane conductance reg..:

Sundaram, K. ; McBennett, K. ; Flask, C..
Journal of Cystic Fibrosis.  21 (2022)  - p. S136 , 2022
Link: https://doi.org/10.1016/..
 
?
10

507 Phase 1/2a randomized, double-blind, placebo-controlled..:

Cohen, A. ; Lechtzin, N. ; McBennett, K....
Journal of Cystic Fibrosis.  21 (2022)  - p. S286 , 2022
Link: https://doi.org/10.1016/..
 
?
11

529: A phase 1b, randomized, double-blind, placebo-controll..:

Boas, S. ; Donaldson, S. ; McBennett, K....
Journal of Cystic Fibrosis.  20 (2021)  - p. S250 , 2021
Link: https://doi.org/10.1016/..
 
?
12

399: Inefficient CF immune response to pneumococcal vaccina..:

Bonfield, T. ; Harrison, L. ; Fletcher, D..
Journal of Cystic Fibrosis.  20 (2021)  - p. S189 , 2021
Link: https://doi.org/10.1016/..
 
?
13

544: Safety and tolerability of single and repeat doses of ..:

Rowe, S. ; Dorgan, D. ; Lascano, J....
Journal of Cystic Fibrosis.  20 (2021)  - p. S257 , 2021
Link: https://doi.org/10.1016/..
 
?
14

259: Implementation of a standardized home spirometry progr..:

Allerton, P. ; Heritage, R. ; McBennett, K..
Journal of Cystic Fibrosis.  20 (2021)  - p. S126 , 2021
Link: https://doi.org/10.1016/..
 
?
15

Triple Therapy for Cystic Fibrosis Phe508del–Gating and –Re..:

Barry, P.J ; Mall, M.A ; Álvarez, A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982185/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15